| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911257 | Lung Cancer | 2012 | 6 Pages |
Abstract
Our results suggest that patients testing positive for EGFR mutations by immunostaining are good candidates for rapid response EGFR-TKI therapy. Immunostaining for EGFR mutation-specific antibodies is a new test for EGFR-TKI inhibition and could be a useful indicator with regard to patient management.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Akihiko Kawahara, Tomoki Taira, Koichi Azuma, Masaki Tominaga, Satoshi Hattori, Mayuko Kawahara, Hideyuki Abe, Tomohiko Yamaguchi, Jun Akiba, Shinzo Takamori, Akihiro Hayashi, Masayoshi Kage,